Diffusion Pharmaceuticals Inc. DFFN
Set alert
4.40 +4.40 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 6.30M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.42
- Beta
- 1.77
- Short ratio
- 0.16
- Inst. own
- 9.32%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2023
- 50-d avg
- 3.66
- 200-d avg
- 5.05
- 1y target
- 40.00
Analyst view
Consensus: buy
Buy
Price target (mean) 40.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 1
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -2.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -2.22 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 16, 2022 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Nov 25, 2020 | H.C. Wainwright | Reiterated | — | Buy |
| Nov 25, 2020 | H.C. Wainwright | Initiated | — | Buy |
| Nov 17, 2020 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Nov 17, 2020 | H.C. Wainwright | Downgrade | Buy | Neutral |